Furthermore, a subset of patients with RA develops functional antibodies to osteoprotegerin (OPG) and the presence of these antibodies has been associated to higher disease activity and increased bone resorption (21). The gene discussed is TNFRSF11B; the disease is rheumatoid arthritis.